{"name":"Xequel Bio, Inc.","slug":"xequel-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWDE4T3JycmlXbUFqeVoyNEoxQl9jT2pyMWgzOFhPS1lTNVlweVNsYU43bU94cnd6ZF9icVB5YWpkU0pxSVFhRURuTEdPY3FhaFVzY01TcE9BU1hONWZmdVJtQVRsVlpEYW5wdDg4SVQ0a3FUdUFaOU5WOUtrR2tTRmVIR2kxMTIyRnJOTTBVcmVHaEI2am9mcXljbm5kWlRleTBCZU85dVNJb0JSRkVqOUh3XzM2Y1NFTzZKTlU3Q0FqWkxlcUNfNg?oc=5","date":"2025-11-12","type":"pipeline","source":"Eyes On Eyecare","summary":"PolyActiva and RareSight to advance long-acting therapies for pediatric IRDs - Eyes On Eyecare","headline":"PolyActiva and RareSight to advance long-acting therapies for pediatric IRDs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxORkpOZ0tqNTIwMzBCUG03b01wZ3BvOVpEazFZdngtZ1RBS0JsYWdwenZCeXprM19udGlkMHhSUnE1OWhFc1czR3NGSTR4cGtMbmJCMHVyakpqdkxmNHRNSGIyMFJxRENFWDI3cTFRbnIwUlU3ZktuR054QlNjQkZqakZVeFI1VlJYWlNTOHJRYjQ1VGo3NEI3bzRPTzJCUUNLY0o3T3JLZVptcTVDRlZuckdXbGxFOUJDazJRUURR?oc=5","date":"2025-07-25","type":"pipeline","source":"Eyes On Eyecare","summary":"Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes - Eyes On Eyecare","headline":"Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQYUZBeDNXUVh0Nzk0eDFaU3RRSFdwSnIxSG9lVFp4MUl3TUhLMExlZnJPNkIxQ0FtSTJNQlFoQk0zako1aDNoNVM5Z1U1V3J4MGZOVzdUazFkRDJpTFd6WWtpVmJQYk1jc3NjYjBaSWpKM1ZTRkFIdWl0Y2hUaldnd3Btdml0WVZmM1V2amtnNVU5b1hfU3d4ekdsQnFLdDBaZkVTSTlFSFM?oc=5","date":"2025-07-17","type":"pipeline","source":"Dallas Innovates","summary":"Australia’s PolyActiva Opens Fort Worth Office With New Locally Based CEO, CFO, and CSO - Dallas Innovates","headline":"Australia’s PolyActiva Opens Fort Worth Office With New Locally Based CEO, CFO, and CSO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQMC1kR193bExQdFd0N0NoMzA3cnlQNWFNb2pFUllZUXRKSFAtbDYza0w4OGs4UGdzNzd0MG5Qb1FRM2VkUVZlZEFKdERsTlB3WVFGN0M0UzhKeDVLS2VQcEEwbGlmNDFQclZ5blp3T1A5ZHVFck9xRUlXcV9nZ0RFT0dlakVvVHdJUlRqM0t3Q3kyanpMR2RhRFE1X2htN2d6VjRvaUlUeTlxUHRUREEtR3FESnFDLTU4QmdDR1MwNklNVk1wTmpOdGlQQkJJaDlvS1JwR2lHbDI2QmticGhKZ1l3dVNESEtMbHJfYkZlVVR0a3Z2cFlpZ0ZKN1g2cmRsRXNwZlB2aWtHWnNIOGpSQS1PMnNsc0xYWFdQTHdnS1BwdG1XckJGajVQTEtFd2ZLODFSb0J2QmR4bTR6ME1mYQ?oc=5","date":"2025-06-18","type":"pipeline","source":"businesswire.com","summary":"PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Financing to Accelerate US Expansion and Clinical Advancement of PREZIA™ Technology Platform - businesswire.com","headline":"PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Financing to Accelerate US Expansion and Clinical A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNN2hsbGdveUItY3AzYlRFbDdrT0dqN3NENjFuVEc3aGltcUptTF9nRmJMR0t5TFJjRElOTTM5QVp6OUN0RzYxVmtmMUdRMU8xTjB3SXhtWmpQdFI3eTI1anFHTUE1ekgwTW5DbTlMbEZpUmRIakVVNXI2NjBLekRxbTdyUkJxOWRoc09JcE84T2p1ZXNOb3VxTGRR?oc=5","date":"2024-10-21","type":"pipeline","source":"openPR.com","summary":"Radiation Dermatitis Treatment Market Revolutionizing Care: - openPR.com","headline":"Radiation Dermatitis Treatment Market Revolutionizing Care:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPOF9BZlRCeVNhMFQwT0pNWVRHWEdNNXN1Y0RNQW44UHplcjY3d0ZnQWtMTXpieEV5d3JqNHBGeGdLbzdCelRfWWVxdXN4cUNmV1FoS1l5Z1YwTVJ6ZHNEb25HcUgydi1zbkZPdGxxS0ZFQUd1WUdPd1d3cFpTNVJ0V0FHckxyVmlmMm80VnVDazRGVTRZOXZqdEtkOTQ?oc=5","date":"2023-05-08","type":"trial","source":"Contract Pharma","summary":"Societal CDMO to Support Xequel Bio’s iNexin Trials - Contract Pharma","headline":"Societal CDMO to Support Xequel Bio’s iNexin Trials","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}